Skip to main content
. Author manuscript; available in PMC: 2022 Feb 22.
Published in final edited form as: J Pharm Pharmacol. 2020 Aug 4;72(12):1865–1878. doi: 10.1111/jphp.13337

Table 2.

Kinetic parameters derived for the oxidation and glucuronidation of isobavachin by HLM, HIM, MLM, MIM, expressed CYP isozymes and recombinant UGT enzymes, respectively (Mean ± SD). All experiments were performed in triplicate

Enzyme Meta. Vmax (pmol/min per mg) Km (S50) (μM) Ki (μM) n CLint (CLmax) (μl/min per mg) Model

HLM M1 508.10 ± 116.90 8.50 ± 2.29 1.67 ± 0.45 N.A. 59.81 ± 21.18 SI
M2 12.92 ± 0.46 2.34 ± 0.38 N.A. N.A. 5.53 ± 0.93 MM
M3 + + + + +
HIM M1 257.10 ± 5.62 2.74 ± 0.21 N.A. N.A. 93.97 ± 7.65 MM
M2 63.34 ± 6.25 3.21 ± 0.65 77.80 ± 28.51 N.A. 19.71 ± 4.43 SI
M3 154.00 ± 3.69 3.52 ± 0.29 N.A. N.A. 43.79 ± 3.72 MM
MLM M1 102.60 ± 4.56 2.90 ± 0.47 N.A. N.A. 35.46 ± 5.98 MM
M2 216.30 ± 25.66 3.36 ± 0.81 65.03 ± 25.52 N.A. 64.32 ± 17.18 SI
M3 98.22 ± 6.54 2.07 ± 0.32 101.3 ± 32.28 N.A. 47.43 ± 7.99 SI
MIM M1 237.3 ± 20.1 4.17 ± 0.72 134.8 ± 58.05 N.A. 56.88 ± 10.89 SI
M2 ++ ++ ++ ++ ++
M3 79.5 ± 11.51 6.93 ± 1.68 46.66 ± 16.41 N.A. 11.48 ± 3.25 SI
CYP1A2 M1 311.60 ± 16.01 5.08 ± 0.54 96.53 ± 14.82 N.A. 61.37 ± 7.22 SI
M2 ++ ++ ++ ++ ++
M3 173.30 ± 61.67 19.81 ± 9.47 17.76 ± 8.78 N.A. 8.75 ± 5.21 SI
CYP2C19 M1 2517.0 ± 627.9 56.54 ± 16.3 10.94 ± 3.27 N.A. 44.52 ± 16.97 SI
M2 ++ ++ ++ ++ ++
M3 1300.0 ± 325.0 16.81 ± 5.02 4.48 ± 1.35 N.A. 77.33 ± 30.10 SI
HLM G1 6948.0 ± 345.6 23.79 ± 1.36 N.A. 1.68 ± 0.15 148.79 ± 9.36 Hill
G2 1600.0 ± 205.2 73.32 ± 11.19 30.98 ± 5.48 N.A. 21.82 ± 4.35 SI
HIM G1 1188.00 ± 73.87 9.77 ± 1.11 134.80 ± 26.42 N.A. 121.62 ± 15.80 SI
G2 394.90 ± 21.03 11.79 ± 1.10 123.60 ± 19.12 N.A. 33.49 ± 3.59 SI
MLM G1 4022.0 ± 122.6 27.75 ± 1.97 N.A. N.A. 144.94 ± 11.20 MM
G2 988.4 ± 179.5 33.39 ± 8.14 48.7 ± 14.79 N.A. 29.60 ± 9.00 SI
MIM G1 2432.0 ± 381.2 18.71 ± 4.52 84.26 ± 29.37 N.A. 129.98 ± 37.45 SI
G2 632.3 ± 40.49 10.13 ± 1.16 110.10 ± 19.77 N.A. 62.42 ± 8.21 SI
UGT1A1 G1 7735.0 ± 1186.0 41.84 ± 8.25 40.82 ± 9.70 N.A. 184.87 ± 46.18 SI
G2 ++ ++ ++ ++ ++
UGT1A6 G1 3822.00 ± 782.40 67.66 ± 16.32 21.97 ± 5.84 N.A. 56.49 ± 17.87 SI
G2 341.90 ± 55.04 31.85 ± 6.28 12.71 ± 2.60 N.A. 10.73 ± 2.73 SI
UGT1A7 G1 3593.00 ± 487.20 32.91 ± 5.76 27.54 ± 5.39 N.A. 109.18 ± 24.17 SI
G2 + + + + +
UGT1A8 G1 1607.00 ± 241.00 34.71 ± 6.45 17.04 ± 3.36 N.A. 46.30 ± 11.05 SI
G2 + + + + +
UGT1A9 G1 3167.00 ± 426.4 15.63 ± 3.12 38.39 ± 8.88 N.A. 202.62 ± 48.80 SI
G2 ++ ++ ++ ++ ++
UGT2B4 G1 81.29 ± 2.05 2.66 ± 0.28 N.A. N.A. 30.59 ± 3.28 MM
G2 + + + + +

+, under the limit of quantification; ++, unable to determine the kinetic parameters in the absence of a full kinetic profile; Hill, Hill equation; HIM, human intestine microsomes; HLM, human liver microsomes; Meta., metabolites; MIM, mouse intestine microsomes; MLM, mouse liver microsomes; MM, Michaelis–Menten model; N.A., not available; SI, substrate inhibition model.